A novel coumarin derivative DBH2 inhibits proliferation and induces apoptosis of chronic myeloid leukemia cells

With the development of tyrosine kinase inhibitor (TKI) resistance, finding the novel effective chemotherapeutic agent is of seminal importance for chronic myelogenous leukemia (CML) treatment. This study aims to find the effective anti-leukemic candidates and investigate the possible underlying mec...

Descripción completa

Detalles Bibliográficos
Autores principales: Xin, Jiajia, Zhang, Huijie, Yin, Dandan, An, Ning, Chen, Yaozhen, Xu, Jinmei, Zhang, Jing, Liu, Zhixin, Liu, Yongsheng, Yin, Wen, Li, Mingkai, Hu, Xingbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chongqing Medical University 2022
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201669/
https://www.ncbi.nlm.nih.gov/pubmed/37223541
http://dx.doi.org/10.1016/j.gendis.2022.08.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201669/
https://www.ncbi.nlm.nih.gov/pubmed/37223541
http://dx.doi.org/10.1016/j.gendis.2022.08.021

Ejemplares similares